Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
High Leverage + Live Trading|BTC Weekly Candle Closes Bullish, Attacks 87,000 Again! ETH Faces Extreme Compression, Catch-up Rally Window Approaching

High Leverage + Live Trading|BTC Weekly Candle Closes Bullish, Attacks 87,000 Again! ETH Faces Extreme Compression, Catch-up Rally Window Approaching

AiCoinAiCoin2026/10/05 09:05
Show original

Over the weekend, trading volume in the market remained dry for two consecutive days, but the bulls did not exit. Instead, they continued to build momentum through low-volatility sideways movement. This persisted until this morning’s weekly close, where BTC was pushed back up to higher levels, ultimately closing the week with a green candle, maintaining the bullish structure’s advantage.

However, the biggest hidden risk at these high levels has also started to emerge—leverage is rapidly being rebuilt.

BTC funding rates have rebounded significantly, indicating that contract bulls are becoming active again. If subsequent spot buying can strengthen at the same pace, this leverage could fuel a breakout; but if the price increases are mainly driven by contract funding and spot demand can’t keep up, there’s a risk of a quick deleveraging pullback.

Risk for ETH is even more pronounced. The retail long-short ratio is highly biased toward longs, while top traders are clearly more restrained in their long positions. This setup means the market is generally bullish, but it also provides sufficient “fuel” for a downside liquidation sweep.

Therefore, while the overall outlook remains bullish at the start of this week, one guiding principle remains:

A bullish trend does not mean chasing rising prices. Buying on pullbacks is better than chasing at high levels; only follow a real breakout if it’s accompanied by strong volume.

₿ BTC

View: Focus primarily on buying the dips, with short positions as a secondary strategy. Pay close attention to whether 87,500–87,800 can truly be broken.

The BTC weekly chart continues to close bullish, further strengthening the medium-term bullish structure.

The 4-hour EMA alignment remains bullish. MACD’s DIF and DEA are above the zero axis. Although upward momentum has weakened, there’s no clear bearish crossover yet, so the structure still favors the bulls.

Meanwhile, the Bollinger Bands keep narrowing, and the price is running close to the upper band—a typical high-level compression and accumulation pattern.

What really warrants vigilance is the zone near 87,500.

Previously, when BTC broke above 87,000, it encountered obvious selling pressure, quickly retraced, and triggered major liquidations. Now that the price has returned to the same region, it means the bulls are making a second attempt.

If this time, trading volume surges and BTC can hold above 87,500–87,800, there is potential for further upside. If it surges on low volume again, beware of history repeating itself.

Therefore:

On pullbacks to 86,000–86,500, prioritize watching for long entries;
At 87,500–87,800, assess the quality of the breakout;
If it breaks out on high volume, then watch for 88,500–89,000.

Support: 86,000–86,500; 84,800–85,300
Resistance: 87,500–87,800; 88,500–89,000

⟠ ETH

View: Focus mainly on buying the dips, watch for catch-up gains, but first guard against retail longs being flushed out.

ETH has noticeably lagged behind BTC recently, with one key reason being the continuous weakening of the ETH/BTC rate.

This puts ETH in an interesting position relative to BTC:

As long as BTC remains stable and the ETH/BTC rate rebounds, ETH could quickly catch up with rapid gains.

Technically, ETH has reached the very end of a narrow converging triangle. Multiple 2-hour moving averages are tightly converged, and the MACD’s fast and slow lines are nearly on the zero axis, indicating the market’s volatility has compressed to extremely low levels.

This kind of standoff won’t last forever.

Once a breakout occurs, the move is often even faster than during the consolidation phase.

On a larger cycle, ETH is still consolidating and building up within a bull market structure, with no clear reversal. However, there is still notable selling pressure in the 2,750–2,800 area. A convincing catch-up move requires the price to break through and hold above this band.

There’s also a need to watch out for crowded retail longs. If the market first chooses to flush out leverage to the downside, the 2,670 or even 2,655 area may be spots to look for fresh long opportunities.

So today, ETH is best approached by:

Buying on dips and avoiding chasing rallies; watch for catch-up gains if the ETH/BTC rate strengthens; look for new upside above 2,800 if it breaks out.

Support: 2,703; 2,670–2,680; 2,655
Resistance: 2,750–2,765; 2,800–2,830

High Leverage + Live Trading|BTC Weekly Candle Closes Bullish, Attacks 87,000 Again! ETH Faces Extreme Compression, Catch-up Rally Window Approaching image 0

15 professional analysts from the community track the market live around the clock. Here, you can not only learn real-world technical analysis methods but also systematically understand hedging strategies and risk control systems.

News Image 0
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Roche secures rights to Alector's Parkinson's therapy for up to $1.27 billions, Alector shares surge

Reuters, October 5 – U.S. biotechnology company Alector announced on Monday that Swiss pharmaceutical giant Roche will pay up to 1.27 billion dollars to obtain licensing rights for its experimental Parkinson's disease therapy. Boosted by this news, Alector’s shares surged 72% in pre-market trading. Genentech, a subsidiary of Roche, will pay Alector a 100 million dollar upfront payment, with an additional payment of up to 1.17 billion dollars if the therapy meets certain developmental, regulatory, and sales milestones. Alector will also receive royalty payments. Specific details are as follows: the agreement grants Genentech exclusive global rights to develop, produce, and commercialize AL050, an experimental therapy targeting enzyme deficiency associated with Parkinson’s disease. Genentech will be responsible for the development, regulatory filings, production, and commercialization of the therapy. AL050 is an enzyme replacement therapy designed to address GCase enzyme deficiency—which leads to the buildup of certain fats and increases the risk of Parkinson’s. This deal is the latest in a series of licensing agreements Roche has reached to expand its drug development pipeline. In June, Roche and Nurix Therapeutics entered into a licensing and collaboration agreement involving a blood cancer medication, with a deal value of up to 2.3 billion dollars.

路透社•2026/10/05 12:16

Harrow Completes Acquisition of Tyrvaya Nasal Spray From Viatris

08:10 AM EDT, 10/05/2026 (MT Newswires) -- Harrow (HROW) said Monday that it has closed its earlier stated acquisition of Tyrvaya from Viatris (VTRS), acquiring worldwide rights to the nasal spray, except for Japan. Harrow said that, in accordance with the terms reported in August, the company paid $30 million in cash at closing and may pay up to $70 million in sales-based milestones. Tyrvaya is an FDA-approved nasal spray for dry eye disease, Harrow said. Harrow said it expects the product to generate more than $30 million in revenue next year.

MT newswire•2026/10/05 12:10

Ecarx Completes Acquisition of Flyme Software Business

08:10 AM EDT, 10/05/2026 (MT Newswires) -- Ecarx (ECX) said Monday that it has closed its acquisition of the entire Flyme software business portfolio, including the Flyme Auto in-vehicle cockpit operating system and a cross-device Flyme operating system. The company said it paid 1.8 billion Chinese renminbi ($266 million) in cash, about 70% of which was funded by syndicated bank loans from Chinese commercial banks and roughly 30% from internal sources. After closing, Ecarx said it will provide the acquired business with 200 million renminbi to support its operations. Shares of Ecarx were up 5.8% pre-bell Monday.

MT newswire•2026/10/05 12:10

BUZZ - US Stock Market Dynamics - RXO, Harley-Davidson, Vistra

Search string for querying individual stock trends in the workspace: STXBZ "Today's Outlook" newsletter: https://refini.tv/3LI4BU7 "Morning News Brief" newsletter: https://refini.tv/3dKUyB8 Reuters, October 5 - On Monday, U.S. stock index futures edged lower as tech stocks retreated after reaching record highs. As Treasury yields and oil prices remain elevated, investors are seeking new clues about the direction of monetary policy. .N ** RXO RXO.N: Market focus — RXO shares rose following C.H. Robinson's announcement of a 5.8 billions USD acquisition plan nL6N45R0N4 ** Harley-Davidson HOG.N: Market focus — Citi upgraded Harley-Davidson to "Buy," shares climbed nL6N45R0M3 ** GEO Group GEO.N: Spotlight — GEO gained as it sold ICE facilities for 950 millions USD and expanded its stock buyback nL6N45R0MR ** Vistra VST.N: Spotlight — Vistra rallied as it was reportedly set to receive a 4.2 billions USD U.S. nuclear loan nL4N45R0L8 ** Vaxcyte PCVX.O: Spotlight — Vaxcyte surged after positive late-stage clinical trial data for its pneumococcal vaccine nL4N45R0K0 ** Estée Lauder EL.N: Spotlight — Barclays upgraded Estée Lauder to "Overweight," shares advanced nL6N45R0HX ** PTC PTC.O: Spotlight — Schneider Electric agreed to acquire PTC for 22.6 billions USD, shares jumped nL6N45R0HV (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automatic translation may contain errors or fail to convey the required context, Reuters does not guarantee the accuracy of automatically translated texts and provides them solely for readers’ convenience. Reuters accepts no liability for any damages or losses arising from the use of automated translation features.)

路透社•2026/10/05 12:06